Andromachi (Machi) Scaradavou, MD

Andromachi (Machi) Scaradavou, MD

Pediatric Hematologic Oncologist

Clinical Expertise

Pediatric Hematology and Oncology; Cord Blood Transplantation for Hematologic Disorders

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Scaradavou accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me

Education

MD, University of Athens Medical School (Greece)

Residencies

Massachusetts General Hospital/Harvard Medical School

Fellowships

Memorial Sloan Kettering Cancer Center; Lindsley f. Kimball Research Institute, New York Blood Center

Board Certifications

Pediatarics; Pediatric Hematology-Oncology

I am a pediatric hematologist and oncologist with extensive experience in the use of cord blood transplants to treat babies, children, and young adults with leukemia, lymphoma, and other cancers and blood diseases.

Umbilical cord blood from healthy newborns is an excellent source of stem cells to rebuild a patient’s immune and blood systems. At Memorial Sloan Kettering, we try to present patients and their families with different treatment options, tailored to their individual situations. Cord blood has a number of advantages over blood or bone marrow from an unrelated donor. It is not necessary to find a perfect HLA (tissue type) match, making it particularly attractive for patients of ethnic minorities. Cord blood is more rapidly available, and there is a lower risk of a serious transplant complication called graft-versus-host disease, which occurs when the transplanted cells attack the normal tissues of the recipient’s body.

My colleagues and I have a great deal of experience in research that has led to cord blood transplantation being brought from the laboratory to the clinic. We are studying new ways to use cord blood to treat diseases of the blood and bone marrow. One approach we use is to increase the number of cord blood cells by combining two units from different donors (called “double-unit transplants”).

I have spoken nationally in support of cord blood transplantation to try to get more hospitals interested in participating in cord blood donation programs. I also teach fellows and give presentations at conferences about cord blood collection and its use in transplantation.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Scaradavou’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.